Showing results (211-220 of 379) with videos related to
Sort By:
Pageof 38
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 31, 2014
Effectiveness and tolerability of ipilimumab: experiences from 198 patients included in a named-patient program in various daily-practice settings and multiple institutionsThomas K Eigentler, Max Schlaak, Jessica C Hassel, et al.JAAD International|June 17, 2024
Checkpoint inhibitor-induced lichen planus differs from spontaneous lichen planus on the clinical, histological, and gene expression levelBarbara Meier-Schiesser, Christine Zecha, Sarah Zierold, et al.Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 22, 2025
Real-world management of adjuvant systemic melanoma therapy: Multi-center survey of 51 DeCOG skin cancer centersMarkus Reitmajer, Elisabeth Livingstone, Lucie Heinzerling, et al.The Journal of Pathology. Clinical Research|January 16, 2026
Alcian blue-positive stromal phenotype in basal cell carcinoma is associated with progression on first-line hedgehog inhibitorsViola K DeTemple, Rudolf Stadler, Sabine Bredemeier, et al.Nature Communications|March 11, 2025
Tebentafusp, a T cell engager, promotes macrophage reprogramming and in combination with IL-2 overcomes macrophage immunosuppression in cancerEsra Güç, Agatha Treveil, Emma Leach, et al.Journal for Immunotherapy of Cancer|September 20, 2023
Treatment management for BRAF-mutant melanoma patients with tumor recurrence on adjuvant therapy: a multicenter study from the prospective skin cancer registry ADOREGMaximilian Haist, Henner Stege, Friederike Rogall, et al.Frontiers in Oncology|August 30, 2021
Apoptotic Gastritis in Melanoma Patients Treated With PD-1-Based Immune Checkpoint Inhibition - Clinical and Histopathological Findings Including the Diagnostic Value of Anti-Caspase-3 ImmunohistochemistryJan-Malte Placke, Josefine Rawitzer, Henning Reis, et al.Cancer Imaging : the Official Publication of the International Cancer Imaging Society|February 6, 2022
Metabolic imaging with FDG-PET and time to progression in patients discontinuing immune-checkpoint inhibition for metastatic melanomaJustin Ferdinandus, Anne Zaremba, Lisa Zimmer, et al.Journal for Immunotherapy of Cancer|May 31, 2019
Metastatic Merkel cell carcinoma and myasthenia gravis: contraindication for therapy with immune checkpoint inhibitors?Anne Zaremba, Eleftheria Chorti, Finja Jockenhöfer, et al.European Journal of Cancer (Oxford, England : 1990)|April 6, 2020
Drug-induced sarcoidosis-like reaction in adjuvant immunotherapy: Increased rate and mimicker of metastasisEleftheria Chorti, Theodora Kanaki, Lisa Zimmer, et al.Pageof 38